- Research works
- 25 ▼ 3% vs 2013–17
- Citations
- 648 26.1 per fractional work
- Top-10% rate
- 22.6% record average 16.5%
- Open access
- 49% world 28%
Not ranked overall: OPX Biotechnologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 12.8×. Every wedge is a field page.
Which keywords describe research at OPX Biotechnologies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Biogenesis, Biomarkers, Drug Delivery, Exosomes, Extracellular Vesicles, Regulation and Gene Therapy.
- MicroRNA
- Therapeutics
- RNA Interference
- Nanoparticles
- Gene Expression
- Extracellular Vesicles
- Drug Delivery
- Biogenesis
- Cancer
- Biomarkers
- Exosomes
- Regulation
- Gene Therapy
- Antioxidant
- Synthetic Biology
- siRNA Delivery
- Targeting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cancer6▲ 16×10 topics
- Biogenesis4▲ 157×3 topics
- Biomarkers4▲ 28×3 topics
- Drug Delivery3▲ 28×2 topics
- Exosomes3▲ 478×1 topic
- Extracellular Vesicles3▲ 478×1 topic
- Regulation1▲ 8.6×3 topics
- Gene Expression1▲ 7.9×2 topics
- Gene Therapy1▲ 19×2 topics
- Nanoparticles1▲ 3.6×4 topics
- Antioxidant1▲ 6.4×9 topics
- RNA Interference1▲ 39×1 topic
- Synthetic Biology1▲ 54×2 topics
- Therapeutics1▲ 33×2 topics
- siRNA Delivery1▲ 58×1 topic
- MicroRNA1▲ 40×1 topic
- Targeting1▲ 70×1 topic
Which research topics does OPX Biotechnologies (United States) publish most on?
By volume in 2022–2025: Extracellular vesicles in disease, MicroRNA in disease regulation, RNA Interference and Gene Delivery and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Extracellular vesicles in disease Molecular Biology 3 works
- 2 MicroRNA in disease regulation Cancer Research 1 works
- 3 RNA Interference and Gene Delivery Molecular Biology 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Cannabis and Cannabinoid Research Pharmacology 0 works
- 6 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 7 Toxin Mechanisms and Immunotoxins Immunology 0 works
- 8 HER2/EGFR in Cancer Research Oncology 0 works
- 9 Circular RNAs in diseases Molecular Biology 0 works
- 10 Hops Chemistry and Applications Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has OPX Biotechnologies (United States)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boulder
- University of Colorado Boulder
- University of Colorado System
- NSF National Center for Atmospheric Research
- Cooperative Institute for Research in Environmental Sciences
- Joint Institute for Laboratory Astrophysics
- Laboratory for Atmospheric and Space Physics
- NSF NCAR High Altitude Observatory
- Institute of Arctic and Alpine Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.